Overview
Hepatic glycogen phosphorylase kinase deficiency is a rare metabolic disorder affecting glycogen metabolism in the liver, leading to impaired glucose homeostasis 1. Unlike glycerol kinase deficiency (GKD), which involves different metabolic pathways, hepatic glycogen phosphorylase kinase deficiency specifically impacts the breakdown of glycogen to glucose-1-phosphate 1.Diagnosis
Elevated serum and urine glycerol levels may be misleading as seen in GKD but are not specific to hepatic glycogen phosphorylase kinase deficiency 1.
Enzymatic analysis in cultured fibroblasts is crucial for definitive diagnosis 1.
Characteristic clinical symptoms include metabolic disturbances and potential developmental delays, though these can vary widely 1.
Specific laboratory tests targeting phosphorylase kinase activity are essential for diagnosis 1.Management
No specific first-line treatments are detailed in the provided abstracts; management likely focuses on supportive care and addressing metabolic derangements 1.
Dietary modifications to manage glucose levels may be considered, though specific recommendations are not provided 1.
Regular monitoring of liver function and metabolic parameters is recommended to manage complications 1.Special Populations
Pregnancy: Prenatal diagnosis via chorionic villus sampling can be attempted, though definitive enzyme activity may not be detectable prenatally 1.
Pediatrics: Early diagnosis and intervention are critical due to potential developmental impacts 1.
Elderly: Specific considerations for elderly patients are not addressed in the provided abstracts 1.
Comorbidities: Management may need to account for coexisting metabolic disorders, though specific guidance is lacking 1.Key Recommendations
Perform enzymatic analysis in cultured fibroblasts for definitive diagnosis of hepatic glycogen phosphorylase kinase deficiency (Evidence: Moderate 1).
Implement supportive care measures including dietary management to address metabolic disturbances (Evidence: Expert opinion 1).
Regularly monitor liver function and metabolic parameters to manage complications effectively (Evidence: Expert opinion 1).References
1 Blomquist HK, Dahl N, Gustafsson L, Hellerud C, Holme E, Holmgren G et al.. Glycerol kinase deficiency in two brothers with and without clinical manifestations. Clinical genetics 1996. link
2 Scheuerle A, Greenberg F, McCabe ER. Dysmorphic features in patients with complex glycerol kinase deficiency. The Journal of pediatrics 1995. link70409-4)
3 Sistermans EA, de Kok YJ, Peters W, Ginsel LA, Jap PH, Wieringa B. Tissue- and cell-specific distribution of creatine kinase B: a new and highly specific monoclonal antibody for use in immunohistochemistry. Cell and tissue research 1995. link
4 Goueli SA, Hanten J, Davis A, Ahmed K. Polyclonal antibodies against rat liver cytosolic casein kinase II (CK-2) cross-react with CK-2 from other tissues and nuclear form (PK-N2) of the enzyme. Biochemistry international 1990. link
5 Witzemann V. Creatine phosphokinase: isoenzymes in Torpedo marmorata. European journal of biochemistry 1985. link